CARCINOMA, PANCREATIC DUCTAL

Clinical trials for CARCINOMA, PANCREATIC DUCTAL explained in plain language.

Never miss a new study

Get alerted when new CARCINOMA, PANCREATIC DUCTAL trials appear

Sign up with your email to follow new studies for CARCINOMA, PANCREATIC DUCTAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2 Terminated 1

Engineered immune cells take on deadly pancreatic cancer in first human trial

Disease control Not yet recruiting

This study tests a new treatment for advanced pancreatic cancer that has not responded to standard therapies. It uses a patient's own immune cells, modified in a lab to target a protein called CD318 found on cancer cells. The goal is to see if this approach is safe and can shrink…

Matched conditions: CARCINOMA, PANCREATIC DUCTAL

Phase: PHASE1, PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control

Last updated May 17, 2026 02:04 UTC

CARCINOMA, PANCREATIC DUCTAL

Get alerted when new CARCINOMA, PANCREATIC DUCTAL trials appear

Engineered immune cells take on deadly pancreatic cancer in first human trial